Cancer Diagnostics: Technology and Business Trends

Table of Contents

CHAPTER 1

• BACKGROUND: TRENDS IN CANCER DIAGNOSTICS
  • 1.1. Summary of Key Trends
  • 1.2. Statistics Showing Impact of the Disease and the Need for Early Diagnosis
  • 1.3. Prospects for Cancer Theranostics

CHAPTER 2

• DEVELOPMENTS IN CANCER IMAGING
  • 2.1. Introduction
  • 2.2. Virtual Colonoscopy (Application of Computed Tomography in Colon Cancer Screening)
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook
  • 2.3. Advances in Breast Cancer Imaging
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook
  • 2.4. Emerging Role of Positron Emission Tomography in Cancer Diagnostics
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook
  • 2.5. In Vivo Diagnostic Monoclonal Antibodies for Imaging Cancers
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook

CHAPTER 3

• DEVELOPMENTS IN CANCER IN VITRO DIAGNOSTICS
  • 3.1. Introduction
    • “Traditional” Tumor Markers
    • Technologies Used for Cancer In Vitro Diagnostics
    • Trends in Cancer In Vitro Diagnostics
  • 3.2. Advances in In Vitro Diagnostic Colorectal Cancer Screening
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook
  • 3.3. Theranostic Applications of Cancer In Vitro Diagnostics: Erbitux and EGFR
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook
  • 3.4. Theranostic Applications of Cancer In Vitro Diagnostics: Applications in Leukemia and Lymphoma Diagnostics
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook
  • 3.5. Changes in DNA Methylation: Application in Cancer Diagnostics
    • Description and Status
    • Potential Impact
    • Competition
    • Outlook
  • 3.6. Selected Advances in the Search for Novel Cancer Biomarkers/Tests

CHAPTER 4

• BUSINESS OUTLOOK
  • 4.1 Business Trends
    • Positron Emission Tomography
    • Breast Imaging: Mammography
    • In Vivo Diagnostic Monoclonal Antibodies
    • In Vitro Cancer Diagnostics
  • 4.2. Company Profiles
    • ABBOTT LABORATORIES
    • ADVANCED RESEARCH TECHNOLOGIES
    • APPLIED IMAGING
    • CARDINAL HEALTH
    • CELERA DIAGNOSTICS
    • CTI MOLECULAR IMAGING
    • DAKOCYTOMATION
    • EPIGENOMICS
    • EXACT SCIENCES
    • GE HEALTHCARE
    • NEOPROBE
    • ONCOMETHYLOME SCIENCES
    • PHILIPS MEDICAL SYSTEMS
    • ROCHE DIAGNOSTICS
    • SIEMENS MEDICAL SOLUTIONS

CHAPTER 5

• EXPERT INTERVIEWS
  • Roger Attick
  • David Bupp
  • Gary Schweikhardt
  • L. Blair Shamel
  • Daryl Sonnichsen, Pharm.D.

References

Glossary

Index